CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study

Jongheon Jung, Kihyun Kim, Sung-Hoon Jung, Sung-Soo Yoon, Jae Hoon Lee, Jin Seok Kim, Ho-Jin Shin, Soo-Mee Bang, Sang Kyun Sohn, Cheolwon Suh, Dok Hyun Yoon, Sun-Young Kong, Chang-Ki Min, Hyeon-Seok Eom,

Cancer Research and Treatment. 2023;55(2):693-703. DOI: https://doi.org/10.4143/crt.2022.952

A Prospective, Multicenter Phase II Study of Consolidation with Cyclophosphamide, Bortezomib and Dexamethasone (CVD) in Patients with Multiple Myeloma after Autologous Stem Cell Transplantation; The KMM130 Study

Hyeon-Seok Eom, Jongheon Jung, Kihyun Kim, Chang Ki Min, Je-Jung Lee, Sung-Soo Yoon, Jae Hoon Lee, Jin Seok Kim, Ho-Jin Shin, Soo-Mee Bang, Sang Kyun Sohn, Cheolwon Suh

Clinical Lymphoma Myeloma and Leukemia. 2019;19(10):e291

Link1 Link2

Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study

Cancer Research and Treatment. 2023;55(2):693-703

Link1

Link2 Link3

Bortezomib-thalidomide-dexamethasoneversusbortezomib-cyclophosphamide-dexamethasone as induction therapy prior to autologous stem cell transplantation in multiple myeloma

Philippe Moreau, Jean-Yves Mary, Michel Attal

British Journal of Haematology. 2014;168(4):605-606

Link1 Link2

Comparison of cyclophosphamide–thalidomide–dexamethasone to bortezomib–cyclophosphamide–dexamethasone as induction therapy for multiple myeloma patients in Brazil

Suelen Vigolo, Joice Zuckermann, Rosane Isabel Bittencourt, Lúcia Silla, Diogo André Pilger

Hematology/Oncology and Stem Cell Therapy. 2017;10(3):135-142

Link1 Link2

Consolidation Therapy with Bortezomib/Lenalidomide/Dexamethasone Versus Bortezomib/Dexamethasone After a Dexamethasone-Based Induction Regimen in Patients with Multiple Myeloma: A Randomized Phase III Trial

Rafael Fonseca, S. Vincent Rajkumar

Clinical Lymphoma and Myeloma. 2008;8(5):315-317

Link1 Link2

Bortezomib, Thalidomide and Dexamethasone Compared to Cyclophosphamide, Bortezomib and Dexamethasone As Induction Therapy for the Treatment of Transplant Eligible Multiple Myeloma: Real World Experience with Multiple Myeloma Patients in Colombia

Julio César Solano

Biology of Blood and Marrow Transplantation. 2020;26(3):S248

Link1 Link2

Cyclophosphamide–Bortezomib–Dexamethasone Compared with Bortezomib–Dexamethasone in Transplantation-Eligible Patients with Newly Diagnosed Multiple Myeloma

A. Figueiredo, H. Atkins, R. Mallick, N. Kekre, A. Kew, A. McCurdy

Current Oncology. 2020;27(2):81-85

Link1 Link2

Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma

Sandra Sauer, Katharina Kriegsmann, Cathleen Nientiedt, Anita Schmitt, Carsten Müller-Tidow, Marc-Steffen Raab, Joseph Kauer

Transfusion Medicine and Hemotherapy. 2023;1-10

Link1 Link2

Consolidation with bortezomib/lenalidomide/dexamethasone post autologous hematopoietic cell transplantation in patients with multiple myeloma: a single-center experience

Imane Abou Dalle, Mohamed A. Kharfan-Dabaja, Ali Bazarbachi, Jean El Cheikh

Clinical Lymphoma Myeloma and Leukemia. 2015;15:S53-S54

Link1 Link2

Complete remission upon bortezomib–dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation

Patrizia Tosi, Elena Zamagni, Delia Cangini, Paola Tacchetti, Giulia Perrone, Michela Ceccolini, Michele Baccarani, Michele Cavo

Annals of Hematology. 2006;85(8):549-551

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.